Wall Street's perspective on oncology drug development.
Healthcare Investment Banking, Merrill Lynch & Co., New York, NY, USA.
Robert H
RH
Glassman
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D007449:Investments; D009369:Neoplasms / Q000188:drug therapy*; D014481:United States
D000970:Antineoplastic Agents